Sorsby's Fundus Dystrophy: A case report to raise awareness of the disease and potential future treatments

Clinical and Experimental Ophthalmology

Volumn 37, Issue 3, 2009, Pages 325-327

  Szental, Joshua A ^a   Harper, Colin A ^a   Baird, Paul N ^a   Michalova, Kira ^a   Guymer, Robyn H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; SERINE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VASCULOTROPIN ANTIBODY;

ADULT; ARTICLE; AWARENESS; CASE REPORT; FAMILY HISTORY; FEMALE; GENETIC IDENTIFICATION; HUMAN; MUTATIONAL ANALYSIS; ONSET AGE; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; RETINA DISEASE; RETINA DYSTROPHY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; SORSBY FUNDUS DYSTROPHY; VISUAL ACUITY;

AMINO ACID SUBSTITUTION; CHOROID; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MIDDLE AGED; PEDIGREE; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; TISSUE INHIBITOR OF METALLOPROTEINASE-3; VISION, LOW; VISUAL ACUITY;

EID: 65449131550     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02025.x     Document Type: Article

References (5)

1. Hoskin AA, Sehmi KK, Bird AAC. Sorsby's pseudoinflammatory macular dystrophy. Br J Ophthalmol 1981; 65: 859-65.
2. Qi JH, Ebrahem Q, Moore N et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): Inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9: 407-15.
3. Li Z, Clarke MP, Barker MD, McKie N. TIMP3 mutation in Sorsby's fundus dystrophy: Molecular insights. Expert Rev Mol Med 2005; 7 (24): 1-15.
4. Polkinghorne PJ, Capon MR, Berninger T, Lyness AL, Sehmi K, Bird AC. Sorsby's fundus dystrophy. A clinical study. Ophthalmology 1989; 96: 1763-8.
5. Miller JW. Preliminary results of gene therapy for retinal degeneration [Comment]. N Engl J Med 2008; 358: 2282-4.